FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's ...
Hosted on MSN8m
Researchers studying whether medical cannabis could help late-stage dementia patients
As research continues, those involved say this would be a game changer, especially for patients with very limited options.